- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02282462
Study of Postoperative Chest Tube Management
June 24, 2020 updated by: Yale University
A Randomized Comparison of Active Suction vs. Passive Chest Tube Drainage and Regulated and Unregulated Pleural Pressure After Anatomic Lung Resection
A 2 x 2 randomized study testing active versus passive drainage and regulated versus unregulated pleural pressure in patients undergoing anatomic lung resection
Study Overview
Status
Completed
Conditions
Detailed Description
This study is a prospective, multi-center randomized clinical trial at 6 sites.
Pre-operative evaluation and the decision for surgical intervention will proceed as currently performed at each center.
That is, neither inclusion in nor exclusion from this study will affect the plan of care for patients other than the approach to chest tube management, which is determined by randomization among 4 methods that are in common clinical use.
Each enrolled patient will be randomized to either regulated pleural pressure using the Thopaz+ digital chest drainage device or unregulated pleural pressure using a traditional system (multi-chambered system e.g.
Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution) and also randomized to either active suction (-20 cm H2O) or passive drainage.
Study Type
Interventional
Enrollment (Anticipated)
600
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06519
- Yale University
-
-
Georgia
-
Marietta, Georgia, United States, 30066
- WellStar Health System - Kennestone
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess/ Harvard
-
-
New Jersey
-
Paramus, New Jersey, United States, 07653
- Valley Health System
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18015
- St. Luke's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able and willing to read, understand, and provide written consent
- Age 18-90
- Undergoing a segmentectomy, lobectomy, or bilobectomy (including sleeve resection). Both open and minimally invasive (thoracoscopic or robotic) resections are acceptable
Exclusion Criteria:
- Patients unstable enough to require ICU care for hemodynamic or respiratory problems during the first 7 days postoperatively. Patients admitted to the ICU for other reasons (e.g. bed availability, institutional norm, routine monitoring etc.) should NOT be excluded
- Patients undergoing non-anatomic lung resection only (i.e. wedge resection)
- Patients undergoing anatomic lung resection for bullous disease, lung abscess or bronchiectasis.
- Patients undergoing pneumonectomy or completion pneumonectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Reg pressure, Active suction (Dig)
Regulated pleural pressure with active suction
|
Regulated Suction using the Thopaz+ digital chest drainage device
Thopaz+ digital chest drainage device set at -20cmH2O at the patient
|
Experimental: Reg pressure, Passive drainage (Dig)
Regulated pleural pressure with passive drainage
|
Regulated Suction using the Thopaz+ digital chest drainage device
Thopaz+ digital chest drainage device set at -8cmH2O at the patient ("physiologic")
|
Experimental: Unreg pressure, Active suction (Trad)
Unregulated pleural pressure with active suction
|
Unregulated Suction using a traditional system (multi-chambered system e.g.
Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution)
Pleur-Evac, Atrium-Maquet or similar set at -20cmH2O at the device.
|
Experimental: Unreg pressure, Passive drainage (Trad)
Unregulated pleural pressure with passive drainage
|
Unregulated Suction using a traditional system (multi-chambered system e.g.
Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution)
Pleur-Evac, Atrium-Maquet or similar set by gravity ("water-seal')
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of air leak
Time Frame: up to 7 days
|
Duration until there is no clinically significant air leak by standard criteria (no bubbles during coughing with a traditional device and a ≥6 hour period with no spikes >80 ml/min and an air flow ≤30 ml/min during passive drainage or ≤50 ml/min during active suction)
|
up to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time till chest tube removal
Time Frame: up to 7 days
|
Duration of time till chest tube is removed.
Chest tube will be removed when resolution of air leak and fluid drainage <= 400 ml/day
|
up to 7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of hospital stay
Time Frame: up to 7 days
|
How long is the total hospital stay
|
up to 7 days
|
Amount of fluid drained
Time Frame: up to 7 days
|
How much fluid is drained while the chest tube is in place
|
up to 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Frank Detterbeck, MD, Yale University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Actual)
December 18, 2017
Study Completion (Actual)
December 18, 2017
Study Registration Dates
First Submitted
October 30, 2014
First Submitted That Met QC Criteria
November 3, 2014
First Posted (Estimate)
November 4, 2014
Study Record Updates
Last Update Posted (Actual)
June 26, 2020
Last Update Submitted That Met QC Criteria
June 24, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1411014891
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Resection
-
Centre Hospitalier Universitaire de Saint EtienneMedtronic - MITGTerminated
-
King Faisal UniversityCompleted
-
Fundación Instituto de Estudios de Ciencias de...Baxter Healthcare Corporation; Instituto de Investigación Biomédica de SalamancaCompletedProlonged Air Leak | Lung ResectionSpain
-
Ethicon Endo-SurgeryCompletedGastric Procedures | Lung Resection ProceduresUnited States
-
Technische Universität DresdenCompletedLiver Resection | Colorectal Resection | Pancreatic Resection | Gastric ResectionGermany
-
Hospital General Universitario Gregorio MarañonInstituto de Salud Carlos IIICompleted
-
hui houNot yet recruitingLaparoscopic Liver Resection | Open Liver ResectionChina
-
Halime Sinem BarutçuNot yet recruitingLung Cancer | Lung Resection | Tele-pulmonary Rehabilitation
-
The Second Hospital of Anhui Medical UniversityRecruitingLaparoscopic Liver Resection | Enhanced Recovery | Hepatolithiasis | Open Liver ResectionChina
-
University of AarhusRegionshospitalet HorsensCompletedTranscervical Resection of Endometrium | Transcervical Resection of Fibroids | Transcervical Resection of PolypDenmark
Clinical Trials on Reg Pressure
-
AnthogyrActive, not recruitingEdentulous | Dental ImplantsSpain, Portugal
-
Mario ArpinatiEuropean CommissionRecruitingChronic Graft Versus Host DiseaseItaly
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHematological Malignancies | Relapse | Regulatory T Cell Depletion
-
Assistance Publique - Hôpitaux de ParisRecruitingHematological Malignancies | Relapse | Regulatory T Cell DepletionFrance
-
Science and Research Centre KoperUniversity of Trieste; University of Franche-ComtéUnknownHealthy
-
Hospital Occidente de KennedyUniversidad El Bosque, BogotáCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationChina
-
University of RegensburgTerminated
-
The University of Texas Medical Branch, GalvestonU.S. Department of EducationWithdrawn
-
Oslo University HospitalUnknownBariatric Surgery Candidate | CholecystectomyNorway